NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院

Clinical TrialsSearch results

Search

Number of results: 52688
  • Recruitment status
  • Title of the study
  • Health Condition
  • Primary sponsor
  • Date of registration
  • Other

  • TBD
  • Taletrectinib is to be indicated for the treatment of adult Japanese patients with ROS1 or NTRK fusi
  • Nakayama Tomoko
  • 2022-01-13

Progress situation









The subject of age and gender

Sex



Age